Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development
Kähkönen, T.E.; Halleen, J.M.; Bernoulli, J. Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development. Cancers 2020, 12, 1615. https://doi.org/10.3390/cancers12061615
Kähkönen TE, Halleen JM, Bernoulli J. Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development. Cancers. 2020; 12(6):1615. https://doi.org/10.3390/cancers12061615
Chicago/Turabian StyleKähkönen, Tiina E., Jussi M. Halleen, and Jenni Bernoulli. 2020. "Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development" Cancers 12, no. 6: 1615. https://doi.org/10.3390/cancers12061615

